ARYx Therapeutics (ARYX) Receives U.S. FDA Guidance Regarding Anticoagulant Agent Tecarfarin
Tweet Send to a Friend
ARYx Therapeutics, Inc. (NASDAQ: ARYX) today announced that is has received guidance in writing from the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
